Santa Monica, United States
BRINTER, a startup founded in 2021 and headquartered in the United States, is pioneering the development of bio-synthetic implants for tissue repair, with an initial focus on tendon and ligament repairs. The company's mission is encapsulated in its slogan: U.S 3D BioPrinted Tissue Platform company [TechStars‘24 Plug & Play '25] - Developing bioimplants for human Repairs.
Having recently secured a $750.00K Seed investment as of 01 February 2023, BRINTER is positioned to capitalize on advancements in 3D bioprinting technology. This capital infusion is intended to propel the company forward in its research and commercialization efforts, offering a promising outlook for future growth in the burgeoning biotech sector.
The startup stands out in the medical tech industry by addressing an unmet need for bio-synthetic implants, making it an attractive consideration for investors seeking innovation in healthcare solutions. As a participant in programs like TechStars and Plug & Play, BRINTER benefits from a network of invaluable resources and mentorship.
